NasdaqStem cell biotech Magenta Therapeutics files for a $100 million IPONasdaqMagenta Therapeutics, which is developing novel therapies to make stem cell transplants more effective, filed on Thursday with the SEC to raise up to $100 million in an init… Continue reading
PLoS Blogs (blog) |
A New Goal for Gene Therapy: Pet Contraception
PLoS Blogs (blog) Might gene therapy provide a one-time, far less invasive way to ensure that cats and dogs do not beget kittens and puppies? That’s one of the goals of the Alliance for Contraception in Cats & Dogs. I’ll be speaking at their annual meeting in July … |
Xconomy |
Immunotherapy Biotech Kiromic Considers San Antonio Move for Cash
Xconomy San Antonio — Kiromic, a Houston-based biotech company with artificial intelligence software that it’s using to develop two experimental cancer immunotherapies, may move to San Antonio—if it gets $200,000 from a city-operated economic development … |
Xconomy |
Immunotherapy Biotech Kiromic Considers San Antonio Move for Cash
Xconomy San Antonio — Kiromic, a Houston-based biotech company with artificial intelligence software that it’s using to develop two experimental cancer immunotherapies, may move to San Antonio—if it gets $200,000 from a city-operated economic development … |
Medscape |
Time to ‘Rethink’ Immunotherapy for Molecularly Driven NSCLC
Medscape West: One concept that we have come to an early conclusion on has been immunotherapy in patients with EGFR mutations or ALK rearrangements. Based on the early work with monotherapy in the second-line setting, we have seen that the subgroup of … |